New York General Group has the world's most advanced science and technology, QTIS (Quantum Theory Informed Superintelligence).

This technology can be applied to a variety of industries, one of which is the pharmaceutical industry. In this case, New York General Group's algorithms have successfully allowed artificial intelligence to develop a new drug from scratch.

【Abstrat of the results of ordering QTIS to develop a new drug. QTIS has developed an entirely new chronic pain relief drug called "QuantumRelief."】

【Result of a similar instruction to a large language model (ChatGPT). Only general descriptions of atomic/molecular simulations and drug discovery were available.】

【QTIS-generated "QuantumRelief" package insert.】

The important point is that it took less than a minute from human instruction to the development of the drug by artificial intelligence. Our artificial intelligence also understands the spatial structure and temporal motion of atoms/molecules based on quantum mechanics, which enables highly accurate drug discovery.

The inputs and outputs to this can be found below.

Perform atomic/molecular simulations to develop new pharmaceuticals.

QTIS is also part of the "New York General Group Categorical Family" and is based on the following technology:

Technical Report

We are currently seeking the following three types of partners:

・Joint research

・Business and capital alliances

・Media Coverage

Please feel free to contact us at the following e-mail address:

info@newyorkgeneralgroup.com